Skip to Main Content

Paper Details

Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Stroke
20
2015
Author NameAffiliation
Opeolu AdeoyeFrom the University of Cincinnati Neuroscience Institute, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Medical University of South Carolina
Jane KhouryFrom the University of Cincinnati Neuroscience Institute, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Medical University of South Carolina
Pooja KhatriFrom the University of Cincinnati Neuroscience Institute, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Medical University of South Carolina
Pamela A SchmitFrom the University of Cincinnati Neuroscience Institute, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Medical University of South Carolina
Arthur PancioliFrom the University of Cincinnati Neuroscience Institute, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Medical University of South Carolina
Joseph P BroderickFrom the University of Cincinnati Neuroscience Institute, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Medical University of South Carolina
  • 1 - 6

Datasets